Skip to main content
. 2010 Mar 15;8(3):162–166. doi: 10.4321/s1886-36552010000300002

Table 1.

Informational corticosteroid conversion and COPD exacerbation management quick facts pocket card distributed to physicians at educational sessions.

Agent Equivalent dose (mg) AI potency Classification
Hydrocortisone 20 1 Short to medium acting GC
Cortisone 25 0.8 Short to medium acting GC
Prednisone 5 4 Short to medium acting GC
Prednisolone 5 4 Short to medium acting GC
Methylprednisolone 4 5 Short to medium acting GC
Triamcinolone 4 5 Intermediate acting GC
Betamethasone 0.6 25-40 Long acting GC
Dexamethasone 0.75 30 Long acting GC
Fludrocortisone 2 10 Mineralocorticoid
AI: Anti-Inflammatory, GC: Glucocorticoid

COPD Exacerbation Management Quick Facts:

  1. COPD guidelines centered around 2008 GOLD recommendations
  2. Prednisone 30-40 mg PO Daily x 7-14 days is recommended exacerbation treatment
    1. No additional benefit seen beyond two weeks of therapy
  3. PO is preferred route of steroid administration over IV